Health Care & Life Sciences » Biotechnology | Beijing Strong Biotechnologies Inc.

Beijing Strong Biotechnologies Inc. A | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
438,789.00
501,352.40
558,144.10
658,855.90
683,449.20
762,786.90
Cost of Goods Sold (COGS) incl. D&A
151,990.00
155,444.40
166,835.80
217,978.50
203,628.10
254,934.30
Gross Income
286,799.00
345,907.90
391,308.20
440,877.50
479,821.00
507,852.60
SG&A Expense
80,683.00
107,690.70
114,129.60
141,711.80
164,423.30
179,015.80
EBIT
205,695.00
237,003.80
275,503.30
299,715.00
314,117.50
327,296
Unusual Expense
-
1,898.40
308.10
-
362.80
3,122.40
Non Operating Income/Expense
905.00
1,530.80
1,322.10
2,005.30
619.60
12,477.60
Interest Expense
262.00
89.10
94.70
107.00
1,990.60
3,451.50
Pretax Income
211,625.00
246,260.20
286,675.30
316,006.00
320,888.40
349,953.80
Income Tax
30,988.00
35,619.30
41,632.00
44,359.90
47,737.00
49,288.50
Consolidated Net Income
180,637.00
210,640.90
245,043.40
271,646.10
273,151.40
300,665.30
Net Income
180,637.00
210,640.90
245,043.40
271,646.10
273,151.40
300,665.30
Net Income After Extraordinaries
180,637.00
210,640.90
245,043.40
271,646.10
273,151.40
300,665.30
Net Income Available to Common
180,637.00
210,640.90
245,043.40
271,646.10
273,151.40
300,665.30
EPS (Basic)
0.45
0.51
0.49
0.54
0.54
0.60
Basic Shares Outstanding
399,198.60
417,110.70
497,720.00
499,891.80
501,837.40
501,108.80
EPS (Diluted)
0.44
0.50
0.49
0.54
0.54
0.57
Diluted Shares Outstanding
408,220.10
417,110.70
497,720.00
499,891.80
501,837.40
527,483
EBITDA
216,474.00
249,104.00
286,824.80
310,679.00
332,567.60
344,927.40
Other Operating Expense
421.00
1,213.50
1,675.40
549.40
1,280.20
1,540.80
Non-Operating Interest Income
1,071.00
3,214.60
6,152.20
11,825.70
9,743.90
10,509.30

About Beijing Strong Biotechnologies

View Profile
Address
5th floor, Kuang Yi Building
Beijing Beijing 100191
China
Employees -
Website http://www.bsbe.com.cn
Updated 07/08/2019
Beijing Strong Biotechnologies, Inc. engages in the research, development, manufacturing and sales of in-vitro diagnostics (IVD) products. The company was founded in 2001 and is headquartered in Beijing, China. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.